123 related articles for article (PubMed ID: 15341441)
1. Use of cytological specimens for p53 gene alteration detection in oral squamous cell carcinoma risk patients.
López M; Aguirre JM; Cuevas N; Anzola M; Videgain J; Aguirregaviria J; Castro A; de Pancorbo MM
Clin Oncol (R Coll Radiol); 2004 Aug; 16(5):366-70. PubMed ID: 15341441
[TBL] [Abstract][Full Text] [Related]
2. Mutated and wild-type p53 expression and HPV integration in proliferative verrucous leukoplakia and oral squamous cell carcinoma.
Gopalakrishnan R; Weghorst CM; Lehman TA; Calvert RJ; Bijur G; Sabourin CL; Mallery SR; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Apr; 83(4):471-7. PubMed ID: 9127380
[TBL] [Abstract][Full Text] [Related]
3. [Expressions of PDCD5 and p53 in oral leukoplakia and oral squamous cell carcinoma].
Zhao XY; Liu HW; Wei MJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):429-32. PubMed ID: 16086069
[TBL] [Abstract][Full Text] [Related]
4. A high prevalence of p53 mutations in pre-malignant oral erythroplakia.
Qin GZ; Park JY; Chen SY; Lazarus P
Int J Cancer; 1999 Jan; 80(3):345-8. PubMed ID: 9935172
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
[TBL] [Abstract][Full Text] [Related]
6. p53 mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma.
Ries JC; Schreiner D; Steininger H; Girod SC
Anticancer Res; 1998; 18(3B):2031-6. PubMed ID: 9677462
[TBL] [Abstract][Full Text] [Related]
7. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.
Saranath D; Tandle AT; Teni TR; Dedhia PM; Borges AM; Parikh D; Sanghavi V; Mehta AR
Oral Oncol; 1999 May; 35(3):242-50. PubMed ID: 10621843
[TBL] [Abstract][Full Text] [Related]
8. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of expression of p53 tumor suppressor gene in human oral squamous cell carcinoma].
Okuno-Ishii N
Kokubyo Gakkai Zasshi; 1993 Mar; 60(1):131-48. PubMed ID: 8482898
[TBL] [Abstract][Full Text] [Related]
10. Detection of human papillomavirus DNA sequences in oral squamous cell carcinomas and their relation to p53 and proliferating cell nuclear antigen expression.
Shindoh M; Chiba I; Yasuda M; Saito T; Funaoka K; Kohgo T; Amemiya A; Sawada Y; Fujinaga K
Cancer; 1995 Nov; 76(9):1513-21. PubMed ID: 8635051
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical analysis of the p53 tumor suppressor gene product in oral leukoplakia].
Kikegawa A
Kokubyo Gakkai Zasshi; 2001 Mar; 68(1):51-9. PubMed ID: 11321806
[TBL] [Abstract][Full Text] [Related]
12. A multiple primary carcinoma consisting of leukoplakia and SCC: a case report with p53 mutation analysis.
Hassan NM; Tada M; Shindoh M; Hamada J; Kashiwazaki H; Shimo T; Ashikaga Y; Yamazaki Y; Sasaki A; Moriuchi T; Inoue N
Anticancer Res; 2010 Nov; 30(11):4773-8. PubMed ID: 21115940
[TBL] [Abstract][Full Text] [Related]
13. Correlation between p53 gene mutations and circulating antibodies in betel- and tobacco-consuming North Indian population.
Ralhan R; Agarwal S; Nath N; Mathur M; Wasylyk B; Srivastava A
Oral Oncol; 2001 Apr; 37(3):243-50. PubMed ID: 11287278
[TBL] [Abstract][Full Text] [Related]
14. [Detection of TP53-mutations in brush biopsies from oral leukoplakias].
Scheifele C; Schlechte H; Bethke G; Reichart PA
Mund Kiefer Gesichtschir; 2002 Nov; 6(6):410-4. PubMed ID: 12447653
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of COX-2 -765G>C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population.
Lin YC; Huang HI; Wang LH; Tsai CC; Lung O; Dai CY; Yu ML; Ho CK; Chen CH
Oral Oncol; 2008 Aug; 44(8):798-804. PubMed ID: 18234542
[TBL] [Abstract][Full Text] [Related]
16. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay.
Kashiwazaki H; Tonoki H; Tada M; Chiba I; Shindoh M; Totsuka Y; Iggo R; Moriuchi T
Oncogene; 1997 Nov; 15(22):2667-74. PubMed ID: 9400993
[TBL] [Abstract][Full Text] [Related]
17. Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma.
Sakata K
J Oral Pathol Med; 1996 Jul; 25(6):302-7. PubMed ID: 8887073
[TBL] [Abstract][Full Text] [Related]
18. Gene promoter hypermethylation in oral rinses of leukoplakia patients--a diagnostic and/or prognostic tool?
López M; Aguirre JM; Cuevas N; Anzola M; Videgain J; Aguirregaviria J; Martínez de Pancorbo M
Eur J Cancer; 2003 Nov; 39(16):2306-9. PubMed ID: 14556921
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic significance of chromosome 17 aberrations and P53 gene mutations as prognostic markers in oral squamous cell carcinoma.
Zedan W; Mourad MI; El-Aziz SM; Salamaa NM; Shalaby AA
Diagn Pathol; 2015 Feb; 10():2. PubMed ID: 25881131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
